Front. Microbiol. Frontiers in Microbiology Front. Microbiol. 1664-302X Frontiers Media S.A. 10.3389/fmicb.2024.1355087 Microbiology Correction Corrigendum: Tranexamic acid in combination with vancomycin or gentamicin has a synergistic effect against staphylococci Benjumea Antonio 1 Díaz-Navarro Marta 2 3 Hafian Rama 4 Cercenado Emilia 2 5 Sánchez-Somolinos Mar 2 Vaquero Javier 1 3 6 Chana Francisco 1 Muñoz Patricia 2 3 5 6 Guembe María 2 3 * 1Department of Orthopaedic Surgery and Traumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain 2Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain 3Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain 4School of Biology, Universidad Complutense de Madrid, Madrid, Spain 5CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain 6School of Medicine, Universidad Complutense de Madrid, Madrid, Spain

Edited and reviewed by: Rustam Aminov, University of Aberdeen, United Kingdom

 *Correspondence: María Guembe mariaguembe@hotmail.com 02 02 2024 2024 15 1355087 09 01 2024 24 01 2024 Copyright © 2024 Benjumea, Díaz-Navarro, Hafian, Cercenado, Sánchez-Somolinos, Vaquero, Chana, Muñoz and Guembe. 2024 Benjumea, Díaz-Navarro, Hafian, Cercenado, Sánchez-Somolinos, Vaquero, Chana, Muñoz and Guembe

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on Tranexamic acid in combination with vancomycin or gentamicin has a synergistic effect against staphylococci by Benjumea, A., Díaz-Navarro, M., Hafian, R., Cercenado, E., Sánchez-Somolinos, M., Vaquero, J., Chana, F., Muñoz, P., and Guembe, M. (2022). Front. Microbiol. 13:935646. doi: 10.3389/fmicb.2022.935646 tranexamic acid bacterial growth antimicrobial effect synergy in vitro model MSII/00008 Instituto de Salud Carlos III10.13039/501100004587 Consejería de Educación, Juventud y Deporte, Comunidad de Madrid10.13039/501100008433 Fundación Mutua Madrileña10.13039/100008061 section-at-acceptance Antimicrobials, Resistance and Chemotherapy

In the published article, there were errors in Table 2 as published. The S. aureus MIC50 fold reductions for gentamicin+TXA 50 mg/ml appeared as 5. This has been corrected to 1. The S. epidermidis MIC50 fold reductions for gentamicin+TXA 10mg/ml appeared as 9. This has been corrected to 8. The corrected Table 2 and its caption appear below.

MIC50 for vancomycin and gentamicin alone and in combination with TXA using the automatized turbidity method.

Treatment S. aureus MIC50 (ranges) mg/L MIC50 fold reductions (no.) S. epidermidis MIC50 (ranges) mg/L MIC50 fold reductions (no.) Overall MIC50 (ranges) mg/L MIC50 fold reductions (no.)
Vancomycin 4 (0.12–16) 16 (16–16) 8 (0.12–16)
Vancomycin+TXA 10 mg/ml 0.03 (0.03–0.06) 8 0.03 (0.03–0.03) 8 0.03 (0.03–0.06) 8
Vancomycin+TXA 50 mg/ml 0.12 (0.03–0.25) 1 8 (0.03–16) 1 4 (0.03–16) 1
Gentamicin 16 (0.06–32) 32 (32–32) 32 (0.06–32)
Gentamicin+TXA 10 mg/ml 0.06 (0.06–0.12) 7 0.12 (0.06–0.25) 8 0.12 (0.06–0.25) 8
Gentamicin+TXA 50 mg/ml 8 (0.06–32) 1 16 (0.06–32) 1 16 (0.06–32) 1

TXA, tranexamic acid; MIC, minimal inhibitory concentration.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.